Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Moore, Steven C; National Natural Science Foundation of China; National Key Project of Research and Development Program of China; US National Institutes of Health
    • بيانات النشر:
      Public Library of Science (PLoS)
    • الموضوع:
      2026
    • Collection:
      PLOS Publications (via CrossRef)
    • نبذة مختصرة :
      Background The association between adiposity and increased liver cancer risk is well-recognized, yet underlying metabolic mechanisms require elucidation. This study aimed to identify metabolic mediators linking adiposity markers to liver cancer and assess their potential causality using two-sample Mendelian randomization (MR) analysis. Methods and findings We conducted a 1:1 matched nested case-control study within a population-based and prospective cohort study—the Shanghai Men’s Health Study (SMHS). The SMHS was initiated in 2002–2006, including 61,469 Chinese men aged 40–74 years, and has been followed up for over 20 years. Targeted metabolomic profiling was performed on baseline plasma samples. Associations between seven anthropometric measurements (body mass index [BMI], waist circumference, waist-to-hip ratio, waist-to-height ratio, a body shape index, hip circumference, and adult weight gain), 186 circulating metabolites, and liver cancer risk were assessed. Linear and conditional logistic regression model adjusted for multiple confounders (including smoking, alcohol drinking, physical activity, chronic hepatitis and cirrhosis, diabetes, etc.) were used. Pathway analysis and network analysis were conducted to explore the biological functions of these metabolites. Parallel mediation analysis was employed to quantify the mediating effects through metabolites. Subsequently, MR analysis was performed to investigate potential causal relationships. This study incorporated 322 incident liver cancer cases and 322 cancer-free controls. Participants diagnosed with liver cancer had higher proportions of seropositive hepatitis B surface antigen (63.7%) compared to their matched controls (6.2%). We identified 27 intermediate metabolites associated with both adiposity markers and liver cancer risk, which formed an interconnected functional network. Pyroglutamic acid demonstrated the most robust consistency, being significantly associated with seven anthropometric measurements (β per doubling with BMI = 0.17; 95% ...
    • الرقم المعرف:
      10.1371/journal.pmed.1004910
    • الدخول الالكتروني :
      https://doi.org/10.1371/journal.pmed.1004910
      https://dx.plos.org/10.1371/journal.pmed.1004910
    • Rights:
      http://creativecommons.org/licenses/by/4.0/
    • الرقم المعرف:
      edsbas.CA30D77C